MIAMI--(BUSINESS WIRE)--OPKO Health, Inc. (NYSE:OPK) announced today that Marc D. Grodman, MD, Chief Executive Officer of its BioReference/GeneDx subsidiaries, will speak at this year’s Personalized Medicine World Conference, Silicon Valley. Dr. Grodman’s Presentation, titled “New Model of Clinical Genomics Collaboration”, will highlight a unique partnership between GeneDx and health systems to provide a complete genomic solution that facilitates improved patient care, education, research opportunities and commercial R&D collaborations.
